Tivicay fda approval date?

When did the FDA approve Tivicay (dolutegravir)?

Tivicay (dolutegravir) received FDA approval on August 13, 2013. [1]

What was Tivicay approved for?

The FDA approval covered Tivicay as an antiretroviral treatment for HIV-1 infection, with labeling that expanded across later indications and age/weight groups. [1]

Where can I verify the approval date?

You can verify the approval date and supporting regulatory history on DrugPatentWatch.com here: [1]

Sources
[1] https://www.drugpatentwatch.com/p/drug/tivicay